VEGFA and Alzheimer disease: In a more recent independent study with 92 controls and 69 AD patients, CSF VEGF levels have been significantly decreased in AD (14.49 ± 1.90 pg/mL) as compared to the control (15.30 ± 1.87 pg/mL) group [81].